The lab director's message came in two parts experts were divided over whether Merck had to pull Vioxx off market.
The could help solve these problems not only by enforcing its own rules by requiring doctors and hospitals to report adverse events when patients use drugs.
FitzGerald and colleagues published two studies in 1999 and in 2001 suggesting that by selectively blocking one of two substances called prostaglandins that lead to inflammation.
Graham responded to his supervisor's suggested revisions in Aug. 13 e-mail that I've gone about as far as I can without compromising my deeply-held conclusions about safety question.
